Endocyte Inc (NASDAQ:ECYT)

9.41
Delayed Data
As of Apr 20
 -0.21 / -2.18%
Today’s Change
1.17
Today|||52-Week Range
11.54
+119.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues12.5K12.5K32.5K12.0K
 
 
 
 
 
Depreciation And Amortization238.3K230.6K232.1K221.5K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.5M9.4M6.9M8.7M
 
 
 
 
 
Research And Development8.0M6.5M4.1M5.2M
 
 
 
 
 
Total Operating Expenses11.7M9.7M7.1M8.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.7M-9.6M-7.1M-8.9M
 
 
 
 
 
Extraordinary Charge0.00-2.3M-16.5M0.00
 
 
 
Other Expenses3.2K-30.6K29.7K11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.5M-11.7M-23.3M-8.6M
 
 
 
 
 
Net Income-11.5M-11.7M-23.3M-8.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.4M42.5M42.6M48.0M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M42.5M42.6M48.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.28-$0.55-$0.18
 
 
 
 
 
EPS Diluted-$0.27-$0.28-$0.55-$0.18